Sano Teaming project (EUR 8.96M) established a dedicated Centre for New Methods in Computational Diagnostics and Personalised Therapy.
SANO CENTRUM ZINDYWIDUALIZOWANEJ MEDYCYNY OBLICZENIOWEJ MIEDZYNARODOWA FUNDACJA BADAWCZA
Polish international research foundation applying high-performance computing and simulation to personalized medicine, clinical decision support, and in silico trials.
Their core work
Sano is a Krakow-based international research foundation building computational medicine — using high-performance computing, simulation, and AI-driven models to personalize diagnosis and therapy. They develop clinical decision support systems and in silico trial methodologies that let medical treatments be tested on virtual patient models before reaching real clinics. In practice, they bridge HPC infrastructure, biomedical modeling, and regulatory science, positioning Poland as a centre for computational health research. Their work matters to hospitals, medical device makers, and pharma companies that need faster, cheaper, evidence-based ways to validate therapies.
What they specialise in
Partner in the ISW project focused on lowering barriers to adoption of In Silico Trials in regulatory and clinical contexts.
HPC and simulation are core keywords of the flagship Sano Teaming project.
CDSS development is listed among the core themes of the Sano centre.
VPH and regulatory science emerge as focus areas through the 2021 ISW project.
ISW explicitly targets regulatory acceptance of simulation-based evidence.
How they've shifted over time
Sano was established in 2019 as a Widening-Participation Teaming centre, with its founding years focused on building HPC-based simulation infrastructure, computational medicine methods, and clinical decision support tools. From 2021 onward the focus shifted from capability-building toward application and standardization: in silico trials, virtual physiological human modeling, and regulatory science for simulation-based evidence. The trend is a clear move from "building the lab" toward "getting simulation accepted as regulatory-grade evidence in healthcare."
Sano is moving from infrastructure-building toward translating computational models into regulator-accepted tools for medical device and drug evaluation — a strong fit for future consortia on digital health regulation, VPH, and AI-in-medicine.
How they like to work
Sano leads when it matters most: the flagship Sano project is a coordinator role with a near EUR 9M budget, while they join existing networks as a specialist partner when the topic aligns with their HPC and simulation expertise. With 23 unique partners across 7 countries in just two projects, they act as a hub connecting Central European computational science to Western European medical research. Collaborators get a serious institutional anchor rather than a one-project satellite.
Two projects have already put Sano in contact with 23 partners across 7 countries, with an obvious Polish anchor and strong links into Western European biomedical and HPC communities.
What sets them apart
Sano is one of very few Central European research centres purpose-built around computational medicine, created through an EU Teaming grant specifically to close the East-West research gap in digital health. Unlike typical university groups, it was designed from day one as an international foundation with HPC infrastructure and a clinical-translation mandate. Partners get both Polish cost structure and a centre explicitly built to meet Western European excellence standards.
Highlights from their portfolio
- SanoA EUR 8.96M Teaming project where Sano is coordinator — it literally created the organization as a new Centre for computational diagnostics and personalized therapy.
- ISWIn Silico World places Sano inside the European effort to make simulation-based evidence regulatory-grade for medicines and medical devices.